Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/9918905
Conclusion of this study
This comparative study suggests that tauroursodeoxycholate has significant advantages over ursodeoxycholate that may be of benefit for long-term therapy in PBC.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study